ClinicalTrials HQ

Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Active, not recruiting · NCT04898894 · Registry updated 2026-10-06
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid LeukemiaHemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute biphenotypic leukemia, acute myeloid leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, myeloid leukemia, neoplasmActive, not recruitingPhase 12026-10-06NCT04898894

4 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
AbbVie340
Gateway for Cancer Research32
Karyopharm Therapeutics Inc25
St. Jude Children's Research Hospital169

8 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Childrens Hospital Of PhiladelphiaPhiladelphiaUnited States18
Cook Children's Medical CenterFort WorthUnited States111
Dana-Farber Cancer InstituteBostonUnited States626
Memorial Sloan-Kettering Cancer CenterNew YorkUnited States63
Rady Children's Hospital-San DiegoSan DiegoUnited States5
St. Jude Children's Research HospitalMemphisUnited States194
UT Southwestern/Simmons Cancer CenterDallasUnited States3
Vanderbilt University Medical CenterNashvilleUnited States427